StockData
Absci Corp logo

Absci Corp (ABSI) shareholders

ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$7.58+0.11 (+1.40%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
88.3%
151M of 172M shares
Institutional holders
197
51 new, 15 sold out
Net institutional buying
25M
In Q2 2026
Insider trades, 12 months
5 buys · 2 sales
Net bought $800.85K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
FMR LLC
Joint filing with Abigail P. Johnson (14.40%)
18,386,84914.40%13G (passive) amendmentMar 31, 2025
BlackRock, Inc.13,396,3107.80%13G (passive) amendmentSep 30, 2026
Sean McClain11,002,7097.20%13G (passive) amendmentSep 30, 2025
Catherine D. Wood
Joint filing with ARK Investment Management LLC (8.60%)
10,955,0898.60%13G (passive) amendmentMar 31, 2025
Phoenix General Partner II LLC
Joint filing with Phoenix Venture Partners II, LP (8.20%)
9,354,6958.20%13G (passive) amendmentSep 30, 2024
ARK Investment Management LLC8,265,9357.20%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ABSIValueChange% of portfolio
FMR LLC25,410,04814.81%$294.50M+2,859,0510.01%
ARK Investment Management LLC12,925,2717.53%$149.80M−800,8980.97%
BlackRock, Inc.12,175,3027.09%$141.11M+920,1080.00%
State Street Corp8,097,3084.72%$93.85M+772,4500.00%
Ameriprise Financial Inc6,991,7634.07%$81.03M+3,811,6220.02%
Redmile Group, LLC6,739,6753.93%$78.11M−1,513,6415.24%
Vanguard Capital Management LLC6,122,6773.57%$70.96M+236,0370.00%
Advanced Micro Devices Inc5,714,2853.33%$66.23M–5.05%
Adage Capital Partners Gp, L.L.C.5,704,8203.32%$66.12MNew0.09%
Two Sigma Investments, LP5,493,4863.20%$63.67M+2,594,7200.05%
D. E. Shaw & Co., Inc.5,239,7543.05%$60.73M+4,589,9370.03%
Geode Capital Management, LLC3,583,1632.09%$41.54M+240,0950.00%
Woodline Partners LP2,700,6751.57%$31.30M−599,4940.10%
Siren, L.L.C.2,474,7641.44%$28.68M+674,7640.58%
Bvf Inc/Il2,361,6741.38%$27.37MNew0.70%
Gem Investment Advisors, LLC2,170,8631.26%$25.16M–15.43%
Baker Bros. Advisors LP2,134,8031.24%$24.74M–0.12%
Goldman Sachs Group Inc1,732,3241.01%$20.08M+1,140,6120.00%
Nuveen, LLC1,723,9791.00%$19.98M+1,381,2900.00%
Voloridge Investment Management, LLC1,602,9160.93%$18.58MNew0.08%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026197151M88.3%51 / 7350 / 1538M13M
Q1 2026164126M73.5%42 / 5439 / 1723M11M
Q4 2025143122M71.2%22 / 5231 / 2030M5M
Q3 202514297M56.4%28 / 5233 / 1616M9M
Q2 202513190M52.2%16 / 5634 / 239M5M
Q1 202513986M49.8%34 / 4932 / 2620M8M
Q4 202413374M43.1%36 / 4233 / 229M7M
Q3 202412272M42.2%29 / 3334 / 1615M6M
Q2 202411168M39.6%30 / 4023 / 3217M10M
Q1 202411461M35.4%53 / 3014 / 628M1M
Q4 20236734M19.7%20 / 2113 / 133M3M
Q3 20236034M19.5%7 / 1718 / 151M2M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

151 funds held ABSI in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ABSIValue% of fundAs of
ARK Genomic Revolution ETF10,287,8935.99%$80.04M5.14%Jul 31, 2026
Fidelity Growth Company Fund7,213,5464.20%$48.69M0.05%May 31, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF5,171,4643.01%$59.94M0.56%Jun 30, 2026
Vanguard Total Stock Market Index Fund4,407,6852.57%$51.09M0.00%Jun 30, 2026
iShares Russell 2000 ETF3,550,9812.07%$41.16M0.05%Jun 30, 2026
Columbia Acorn Fund2,889,0661.68%$33.48M1.21%Jun 30, 2026
Columbia Small Cap Growth Fund2,266,3891.32%$15.30M0.42%May 31, 2026
Fidelity Growth Company K6 Fund2,262,1721.32%$15.27M0.06%May 31, 2026
Fidelity Series Growth Company Fund1,971,9861.15%$13.31M0.05%May 31, 2026
Vanguard Extended Market Index Fund1,576,1190.92%$18.27M0.02%Jun 30, 2026
Select Biotechnology Portfolio1,540,7960.90%$10.40M0.20%May 31, 2026
Fidelity Small Cap Index Fund1,514,9650.88%$11.79M0.03%Jul 31, 2026
iShares Russell 2000 Growth ETF1,066,5030.62%$12.36M0.08%Jun 30, 2026
Nuveen Quant Small Cap Equity Fund975,4900.57%$7.59M0.19%Jul 31, 2026
iShares Biotechnology ETF942,5440.55%$10.92M0.12%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Sean McClainChief Executive Officer, Director10,822,3896.31%Oct 30, 2026
Todd BedrickSVP, CAO199,1280.12%Oct 14, 2026
Zachariah JonassonCFO / CBO484,9180.28%Oct 14, 2026
Ransi Mudalinayake SomaratneCMO, Head of R&D––Aug 7, 2026
Andreas BuschChief Innovation Officer421,4460.25%Mar 16, 2026
Shelby J. WalkerChief Legal Officer139,7750.08%Mar 16, 2026
Mary T. SzelaDirector21,3000.01%Jul 6, 2026
Karen K. McGinnisDirector48,4200.03%Jun 11, 2026
Menelas N. PangalosDirector242,4080.14%Jun 8, 2026
Daniel A. RabinovitsjDirector33,4200.02%Jun 8, 2026
Joseph SiroshDirector33,4200.02%Jun 8, 2026
Houten Frans VanDirector73,4200.04%Jun 8, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Sean McClain
Chief Executive Officer, Director
Oct 29, 2026Tax withholding−79,860$12.10$966.31K8,552,402
Sean McClain
Chief Executive Officer, Director
Oct 12, 2026Tax withholding−23,293$10.16$236.66K8,632,262
Todd Bedrick
SVP, CAO
Oct 12, 2026Tax withholding−22,325$10.16$226.82K199,128
Zachariah Jonasson
CFO / CBO
Oct 12, 2026Tax withholding−387$10.16$3.93K484,918
Zachariah Jonasson
CFO / CBO
Aug 31, 2026Tax withholding−8,320$8.71$72.47K483,144
Mary T. Szela
Director
Jun 30, 2026Buy+12,900$11.54$148.87K21,300
Sean McClain
Chief Executive Officer, Director
Jun 24, 2026Tax withholding−59,896$10.08$603.75K8,655,555
Mary T. Szela
Director
Jun 4, 2026Award+8,400––8,400
Karen K. McGinnis
Director
Jun 4, 2026Award+10,100––48,420
Mary T. Szela
Director
Jun 4, 2026Award+10,100––10,100
Menelas N. Pangalos
Director
Jun 4, 2026Award+10,100––242,408
Houten Frans Van
Director
Jun 4, 2026Award+10,100––73,420
Daniel A. Rabinovitsj
Director
Jun 4, 2026Award+10,100––33,420
Joseph Sirosh
Director
Jun 4, 2026Award+10,100––33,420
Zachariah Jonasson
CFO / CBO
May 31, 2026Tax withholding−8,319$6.75$56.15K491,464
Menelas N. Pangalos
Director
May 13, 2026Buy+37,453$5.36$200.75K232,308
Andreas Busch
Chief Innovation Officer
Mar 12, 2026Buy+100,000$2.29$229.00K421,446
Sean McClain
Chief Executive Officer, Director
Mar 3, 2026Tax withholding−25,316$2.80$70.88K8,715,451
Shelby J. Walker
Chief Legal Officer
Mar 3, 2026Tax withholding−9,825$2.80$27.51K139,775
Todd Bedrick
SVP, CAO
Mar 3, 2026Tax withholding−5,282$2.80$14.79K216,942
Zachariah Jonasson
CFO / CBO
Mar 3, 2026Tax withholding−10,848$2.80$30.37K499,783
Sean McClain
Chief Executive Officer, Director
Mar 3, 2026Tax withholding−25,316$2.80$70.88K8,715,451
Todd Bedrick
SVP, CAO
Mar 3, 2026Tax withholding−5,282$2.80$14.79K216,942
Shelby J. Walker
Chief Legal Officer
Mar 3, 2026Tax withholding−9,825$2.80$27.51K139,775
Andreas Busch
Chief Innovation Officer
Mar 3, 2026Tax withholding−1,257$2.80$3.52K321,446
Zachariah Jonasson
CFO / CBO
Mar 3, 2026Tax withholding−10,848$2.80$30.37K499,783
Sean McClain
Chief Executive Officer, Director
Mar 2, 2026Award+406,200––8,740,767
Shelby J. Walker
Chief Legal Officer
Mar 2, 2026Award+90,300––149,600
Todd Bedrick
SVP, CAO
Mar 2, 2026Award+49,600––222,224
Zachariah Jonasson
CFO / CBO
Mar 2, 2026Award+135,400––510,631
Menelas N. Pangalos
Director
Mar 2, 2026Award+5,800––194,855
Sean McClain
Chief Executive Officer, Director
Mar 2, 2026Award+406,200––8,740,767
Todd Bedrick
SVP, CAO
Mar 2, 2026Award+49,600––222,224
Shelby J. Walker
Chief Legal Officer
Mar 2, 2026Award+90,300––149,600
Zachariah Jonasson
CFO / CBO
Mar 2, 2026Award+135,400––510,631
Zachariah Jonasson
CFO / CBO
Mar 2, 2026Tax withholding−8,307$2.74$22.76K375,231
Menelas N. Pangalos
Director
Feb 27, 2026Buy+75,095$2.74$205.76K189,055
Sean McClain
Chief Executive Officer, Director
Feb 23, 2026Tax withholding−267,008$2.65$707.57K8,463,958
Sean McClain
Chief Executive Officer, Director
Feb 23, 2026Option exercise+396,399$1.21$479.64K8,730,966
Andreas Busch
Chief Innovation Officer
Feb 3, 2026Tax withholding−1,469$2.99$4.39K322,703
Zachariah Jonasson
CFO / CBO
Feb 2, 2026Tax withholding−17,496$2.99$52.31K383,538
Sean McClain
Chief Executive Officer, Director
Feb 2, 2026Tax withholding−26,761$2.99$80.02K8,334,567
Zachariah Jonasson
CFO / CBO
Feb 2, 2026Sale−17,496$2.99$52.31K383,538
Todd Bedrick
SVP, CAO
Feb 2, 2026Tax withholding−3,659$2.99$10.94K172,624
Sean McClain
Chief Executive Officer, Director
Feb 2, 2026Sale−26,761$2.99$80.02K8,334,567
Todd Bedrick
SVP, CAO
Jan 28, 2026Award+15,000––176,283
Houten Frans Van
Director
Dec 5, 2025Buy+40,000$3.72$148.80K63,320
Zachariah Jonasson
CFO / CBO
Nov 30, 2025Tax withholding−8,320$3.17$26.37K401,034
Andreas Busch
Chief Innovation Officer
Oct 14, 2025Tax withholding−3,092$3.68$11.38K324,172
Zachariah Jonasson
CFO / CBO
Oct 14, 2025Tax withholding−387$3.68$1.42K409,354
Sean McClain
Chief Executive Officer, Director
Oct 14, 2025Tax withholding−23,293$3.68$85.72K8,361,328
Todd Bedrick
SVP, CAO
Oct 14, 2025Tax withholding−21,950$3.68$80.78K161,283
Menelas N. Pangalos
Director
Sep 22, 2025Buy+95,785$2.66$254.79K113,960
Todd Bedrick
SVP, CAO
Sep 22, 2025Buy+10,000$2.70$27.00K180,428
Zachariah Jonasson
CFO / CBO
Aug 31, 2025Tax withholding−8,319$2.39$19.88K409,741
Andreas Busch
Chief Innovation Officer
Jul 28, 2025Buy+50,000$3.04$152.00K327,264
Houten Frans Van
Director
Jun 11, 2025Award+14,500––23,320
Karen K. McGinnis
Director
Jun 11, 2025Award+14,500––38,320
Joseph Sirosh
Director
Jun 11, 2025Award+14,500––23,320
Menelas N. Pangalos
Director
Jun 11, 2025Award+14,500––18,175

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
24.71%
36M shares short
Days to cover
9.1
At 4M shares a day
Change since last report
-3.2%
From 37M shares
Short volume, 20 days
49.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Absci's stock actually held short. Settlement fails (shares not delivered on time) peaked at 20,300 shares on Aug 24, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Zachariah Jonasson
Officer
Jun 13, 202419,859$98.89KJun 13, 2024Stock Option Exercise

See a number that looks wrong?